Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bluelene is a science-based skincare company founded by Mblue Labs, specializing in anti-aging products powered by Methylene Blue. Developed by Dr. Kan Cao, a professor at the University of Maryland, the company's core technology leverages the antioxidant properties of Methylene Blue to stimulate collagen and elastin production. The patented formulations are designed to protect skin cells from oxidative stress and improve cellular longevity. Bluelene's product line includes a variety of topical treatments such as night creams, serums, and sunscreens. The company bridges the gap between traditional biotechnology and consumer cosmeceuticals through its research-backed approach to skin health. Peer-reviewed studies support the efficacy of their primary ingredient in promoting DNA repair and skin cell viability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bluelene.